Primary Record
Valdecoxib
- In stock
- 3,317 g
- Purity
- 98.5 %
- CAS
- 181695-72-7
Compound Identifiers & Properties
- CAS
- 181695-72-7
- PubChem CID
- 119607
- SMILES
- CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
- Canonical SMILES
- Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1
Names & Synonyms
- Valdecoxib
- Bextra
- 181695-72-7
- Valdyn
- Kudeq
- valdecoxibum
- Valecoxib
- Valdecoxib [USAN]
- Vatdecoxib
- Valdecoxib/
- 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide
- Bextra(Valdecoxib)
- SC-65872
- Parecoxib Impurity 2
- SC 65872
- Bextra (TN)
- Valdecoxib-13C2,15N
- Valdecoxib (Standard)
- Valdecoxib (USAN/INN)
- Spectrum_001747
- 2aw1
- CHEMBL865
- RefChem:56405
- VALDECOXIB [MI]
- Valdecoxib-13C2, 15N
- VALDECOXIB [INN]
- Spectrum2_000508
- Spectrum3_001001
- Spectrum4_001129
- Spectrum5_001476
- VALDECOXIB [HSDB]
- 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide
- Pfizer brand of valdecoxib
- DTXSID6044226
- VALDECOXIB [VANDF]
- D0L6DA
- HSDB 7302
- Valdecoxib [USAN:INN:BAN]
- SCHEMBL3356
- VALDECOXIB [MART.]
- Benzenesulfonamide, 4-(5-methyl-3-phenyl-4-isoxazolyl)-
- LNPDTQAFDNKSHK-UHFFFAOYSA-N
- VALDECOXIB [WHO-DD]
- MFCD00950568
- YM-974
- BSPBio_002721
- DTXCID4024226
- KBioGR_001617
- KBioSS_002227
- C16H14N2O3S
- cc-671
- CHEBI:63634
- MLS000759433
- MLS001165699
- MLS001195631
- MLS001424105
- NSC-759846
- SPECTRUM1504302
- VALDECOXIB [EMA EPAR]
- SPBio_000435
- AC1L3P42
- cid_119607
- GTPL2894
- orb1310822
- UNII-2919279Q3W
- ZINC6694
- VALDECOXIB [ORANGE BOOK]
- Valdecoxib, >=98% (HPLC)
- BDBM13063
- CTK8E7482
- ERK5-3D04
- KBio2_002227
- KBio2_004795
- KBio2_007363
- KBio3_001941
- KS-00000XKX
- EX-A241
- M01AH03
- MSK8007
- Valdecoxib m-Sulfonamide Impurity
- GLXC-05758
- HMS1922J21
- HMS2051P07
- HMS2232P23
- HMS3372D12
- HMS3393P07
- HMS3652I04
- HMS3715L18
- HMS3885O20
- HMS5082A04
- Pharmakon1600-01504302
- 4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide
- AMY31078
- BCP02419
- ND-0214
- 4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonamide
- p-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide
- Tox21_111438
- ABP000351
- AC-120
- C16-H14-N2-O3-S
- CCG-39589
- CID119607
- EBC-26753
- HY-15762R
- NCGC00095129-01
- NP3137
- NSC759846
- s4049
- 2919279Q3W
- AKOS000280920
- Tox21_111438_1
- 4-(5-methyl-3-phenyl-isoxazol-4-yl)benzenesulfonamide
- ACN-053782
- CID:119607
- CS-1674
- CS-W-00221
- DB00580
- FV28650
- NC00184
- NSC 759846
- RL02316
- SB19519
- MRF-0000216
- NCGC00095129-02
- NCGC00095129-03
- NCGC00095129-06
- Valdecoxib, analytical reference material
- AJ-08285
- AK122221
- AN-16123
- BC209355
- CPD000466327
- HY-15762
- SAM001246603
- SC-19235
- SID:53789038
- SMR000466327
- SY115891
- ZB000648
- 3-(4-Methoxyphenyl)-1-phenyl-1H-pyrazole
- AB0125618
- DB-044435
- LS-173713
- RT-016210
- UNM-0000305814
- 4-(5-methyl-3-phenyl-4-isoxazolyl) benzenesulfonamide
- 4CH-003246
- B1459
- CAS-181695-72-7
- FT-0631199
- FT-0675755
- NS00009831
- ST24042991
- SW197564-2
- J1.302.764A
- PARECOXIB IMPURITY F (REFERENCE GRADE)
- A13342
- C21552
- D02709
- 4-(Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide
- AB00639996-08
- AB00639996_10
- EN300-7393031
- 3-Phenyl-4-(4-sulfamoylphenyl)-5-methylisoxazole
- 695V727
- A812629
- C406224
- F320060
- Q347613
- SR-01000759421
- 1189428-23-6
- SR-01000759421-4
- 4-(3-Phenyl-5-methyl-4-isoxazolyl)benzenesulfonamide
- 4-(3-Phenyl-5-methylisoxazole-4-yl)benzenesulfonamide
- 4-[3-Phenyl-5-methylisoxazole-4-yl]benzenesulfonamide
- 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
- 4-[5-methyl-3-phenylisoxazol-4-yl]benzensulfonamide
- BRD-K12994359-001-02-8
- BRD-K12994359-001-14-3
- BRD-K12994359-001-18-4
- I14-44902
- 4-(5-Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide
- COX
- Valdecoxib, 98%, a COX-2 selective inhibitor - 1G 1g
- N0001-010445
- Benzenesulfonamide, 4-(5-methyl-3-phenyl-4-isoxazolyl)-(9CI)
- Benzenesulfonamide, 4-(5-methyl-3-phenyl-4-isoxazolyl)- (9CI)
- Benzenesulfonamide, 4-?(5-?methyl-?3-?phenyl-?4-?isoxazolyl)?-
- 4-[3-Phenyl-5-(trideuteriomethyl)-1,2-oxazol-4-yl]benzenesulfonamide
- 4-(5-(113C)methyl-3-phenyl-(513C,215N)1,2-oxazol-4-yl)benzenesulfonamide
- 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide; 4-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonamide; Bextra; SC 65872; Valdecoxib; Valecoxib; Valus; Valz; Vx 2; Benzenesulfonamide, 4-(5-methyl-3-phenyl-4-isoxazolyl)-
- 448-010-8
- InChI=1/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20
- VLX